Nicolas Engrand
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nicolas Engrand has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
Vera Dinkelacker
Neurology Department, University of Strasbourg, Hautepierre Hospital, 5, Avenue Molière, 67200 Strasbourg, France
5 shared publicationsGérard Audibert
3 shared publicationsMikael Mazighi
Interventional Neuroradiology Department, Fondation Ophtalmologique Rothschild, 75019 Paris, France
3 shared publications- Simon Escalard
Interventional Neuroradiology Department, Hôpital Fondation A. de Rothschild, Paris, France
3 shared publications Armelle Nicolas-Robin
Neuro-intensive Care Unit, Rothschild Hospital Foundation, Paris, France
2 shared publicationsDorian Chauvet
Intensive Care Unit – Anesthesiology (MR, SW, MC, NE), Rothschild Foundation Hospital; Neurosurgery Department (DC, PB), Rothschild Foundation Hospital
2 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by Elsevier in Anesthésie & Réanimation
- Vol. 12 (6) , 565-573
Interopérabilité et éthique des données de santé : enjeux et défis de Mon Espace Santé
- 4 November 2026
- Published by Elsevier in Anesthésie & Réanimation
- Vol. 12 (6) , 565-573
Open AccessInteropérabilité et éthique des données de santé : enjeux et défis de Mon Espace Santé
- Open Access
- 1 November 2026
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 6 (6)
Predictors of Hemorrhagic Transformation After IV Continuous Cangrelor Infusion Initiated During Mechanical Thrombectomy
BACKGROUND: Cangrelor, a fast-acting intravenous P2Y12 receptor inhibitor, is increasingly used during mechanical thrombectomy for acute ischemic stroke to treat or prevent thrombotic complications. While effective, its use may increase the risk of hemorrhagic transformation (HT). We investigated clinical, imaging, and procedural predictors of HT in this specific patient population. METHODS: We performed a retrospective post hoc single-center study including 101 patients with acute ischemic stroke treated with intravenous cangrelor initiated directly after mechanical thrombectomy and continued for 12 hours between January 2021 and June 2024. Univariate and multivariable logistic regression models were used to assess associations between HT and clinical, radiological, and procedural factors. RESULTS: Among the 101 patients included, 25 (24.7%) developed HT, and 9 (8.9%) experienced symptomatic intracerebral hemorrhage. In multivariable analysis, baseline blood glucose (adjusted odds ratio, 6.51 [95% CI, 1.35–31.4]; P =0.02), leukocytosis (adjusted odds ratio, 1.18 [95% CI, 1.00–1.38]; P =0.047), and subarachnoid hemorrhage on postmechanical thrombectomy cone-beam computed tomography (adjusted odds ratio, 16.60 [95% CI, 2.97–92.8]; P =0.0014) were independent predictors of HT. Contrast enhancement was associated with HT in univariate analysis but did not remain significant after adjustment. CONCLUSIONS: Baseline blood glucose, leukocytosis, and isolated subarachnoid hemorrhage on postmechanical thrombectomy cone-beam computed tomography emerged as independent predictors of HT. Identifying high-risk patients using readily available clinical and imaging markers may support individualized antiplatelet strategies and help reduce hemorrhagic complications during cangrelor treatment. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03776877.
- 1 November 2026
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 6 (6)
Open AccessPredictors of Hemorrhagic Transformation After IV Continuous Cangrelor Infusion Initiated During Mechanical Thrombectomy
BACKGROUND: Cangrelor, a fast-acting intravenous P2Y12 receptor inhibitor, is increasingly used during mechanical thrombectomy for acute ischemic stroke to treat or prevent thrombotic complications. While effective, its use may increase the risk of hemorrhagic transformation (HT). We investigated clinical, imaging, and procedural predictors of HT in this specific patient population. METHODS: We performed a retrospective post hoc single-center study including 101 patients with acute ischemic stroke treated with intravenous cangrelor initiated directly after mechanical thrombectomy and continued for 12 hours between January 2021 and June 2024. Univariate and multivariable logistic regression models were used to assess associations between HT and clinical, radiological, and procedural factors. RESULTS: Among the 101 patients included, 25 (24.7%) developed HT, and 9 (8.9%) experienced symptomatic intracerebral hemorrhage. In multivariable analysis, baseline blood glucose (adjusted odds ratio, 6.51 [95% CI, 1.35–31.4]; P =0.02), leukocytosis (adjusted odds ratio, 1.18 [95% CI, 1.00–1.38]; P =0.047), and subarachnoid hemorrhage on postmechanical thrombectomy cone-beam computed tomography (adjusted odds ratio, 16.60 [95% CI, 2.97–92.8]; P =0.0014) were independent predictors of HT. Contrast enhancement was associated with HT in univariate analysis but did not remain significant after adjustment. CONCLUSIONS: Baseline blood glucose, leukocytosis, and isolated subarachnoid hemorrhage on postmechanical thrombectomy cone-beam computed tomography emerged as independent predictors of HT. Identifying high-risk patients using readily available clinical and imaging markers may support individualized antiplatelet strategies and help reduce hemorrhagic complications during cangrelor treatment. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03776877.
- 2 October 2026
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
Practical efficiency of coupling targeted temperature management to brain temperature versus systemic temperature in febrile brain-injured patients. The Brain-TTM study: A randomized controlled pathophysiology trial
Background: Targeted temperature management (TTM) is widely used to prevent secondary brain injury in febrile brain-injured patients, and it almost always targets systemic temperature (ST). However, because the therapeutic target is the brain, brain temperature (BT) may represent a more relevant target. We investigated whether BT-targeted TTM improved BT control compared with conventional ST-targeted TTM. Methods: Brain-TTM was a single-center, prospective, randomized controlled pathophysiology study including brain-injured patients monitored with an intracerebral pressure probe incorporating a thermal sensor. Patients with BT ⩾38.5°C requiring TTM were randomized to BT-targeted or ST-targeted (bladder temperature) TTM. BT and ST were recorded every minute for 12 h. Results: Thirty-four patients were included (17 per group). Median age was 46 years (IQR 42–53), and 68% were men. During the maintenance phase (H3–H12), the median proportion of time with BT within the target range (36.0–37.0°C) was 84% (IQR 53–99) in the BT-targeted group and 89% (IQR 63–92) in the ST-targeted group (primary outcome, p = 0.88). Target attainment at H3 was similar ( p = 0.49). The BT–ST gradient increased from 0.11 ± 0.07°C during induction to 0.30 ± 0.06°C during maintenance. Per-protocol analyses were consistent. Conclusion: BT-targeted TTM did not improve BT control compared with ST-targeted TTM. Trial registration: The trial was registered at ClinicalTrials.gov on 2019-05-29 (NCT03967626).
- 2 October 2026
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
Practical efficiency of coupling targeted temperature management to brain temperature versus systemic temperature in febrile brain-injured patients. The Brain-TTM study: A randomized controlled pathophysiology trial
Background: Targeted temperature management (TTM) is widely used to prevent secondary brain injury in febrile brain-injured patients, and it almost always targets systemic temperature (ST). However, because the therapeutic target is the brain, brain temperature (BT) may represent a more relevant target. We investigated whether BT-targeted TTM improved BT control compared with conventional ST-targeted TTM. Methods: Brain-TTM was a single-center, prospective, randomized controlled pathophysiology study including brain-injured patients monitored with an intracerebral pressure probe incorporating a thermal sensor. Patients with BT ⩾38.5°C requiring TTM were randomized to BT-targeted or ST-targeted (bladder temperature) TTM. BT and ST were recorded every minute for 12 h. Results: Thirty-four patients were included (17 per group). Median age was 46 years (IQR 42–53), and 68% were men. During the maintenance phase (H3–H12), the median proportion of time with BT within the target range (36.0–37.0°C) was 84% (IQR 53–99) in the BT-targeted group and 89% (IQR 63–92) in the ST-targeted group (primary outcome, p = 0.88). Target attainment at H3 was similar ( p = 0.49). The BT–ST gradient increased from 0.11 ± 0.07°C during induction to 0.30 ± 0.06°C during maintenance. Per-protocol analyses were consistent. Conclusion: BT-targeted TTM did not improve BT control compared with ST-targeted TTM. Trial registration: The trial was registered at ClinicalTrials.gov on 2019-05-29 (NCT03967626).
- 24 July 2026
- Published by Taylor & Francis in British Journal Of Neurosurgery
- p. 1-2
Long-term mortality, cognition, and quality of life after chronic subdural hematoma surgery: could spontaneous intracranial hypotension represent a missing contributor?
In a monocentric population-matched cohort study, Petutschnigg et al. reported significant excess long-term mortality, cognitive decline, and impaired health-related quality of life following surge...
- 24 July 2026
- Published by Taylor & Francis in British Journal Of Neurosurgery
- p. 1-2
Long-term mortality, cognition, and quality of life after chronic subdural hematoma surgery: could spontaneous intracranial hypotension represent a missing contributor?
In a monocentric population-matched cohort study, Petutschnigg et al. reported significant excess long-term mortality, cognitive decline, and impaired health-related quality of life following surge...
- 6 April 2026
- Published by Elsevier in Anesthésie & Réanimation
- Vol. 12 (3) , 275-286
Prise en charge périopératoire d’un patient porteur d’un dispositif implantable à visée de neuromodulation
- 6 April 2026
- Published by Elsevier in Anesthésie & Réanimation
- Vol. 12 (3) , 275-286
Prise en charge périopératoire d’un patient porteur d’un dispositif implantable à visée de neuromodulation
- 5 June 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 256, 108997
Twist-drill craniostomy with pressure-controlled fibrinolytic irrigation therapy reduces recurrence of chronic subdural hematomas: Could spontaneous intracranial hypotension be more common during chronic subdural hematomas than we diagnose?
- 5 June 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 256, 108997
Twist-drill craniostomy with pressure-controlled fibrinolytic irrigation therapy reduces recurrence of chronic subdural hematomas: Could spontaneous intracranial hypotension be more common during chronic subdural hematomas than we diagnose?
- 4 January 2025
- Published by Elsevier in The Lancet
- Vol. 405 (10472) , 30-31
Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trial
- 4 January 2025
- Published by Elsevier in The Lancet
- Vol. 405 (10472) , 30-31
Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trial
- Open Access
- 3 October 2024
- Published by Springer Nature in Critical Care
- Vol. 28 (1) , 1-3
What criteria for neuropronostication: consciousness or ability? The neuro-intensivist’s dilemma
- 3 October 2024
- Published by Springer Nature in Critical Care
- Vol. 28 (1) , 1-3
Open AccessWhat criteria for neuropronostication: consciousness or ability? The neuro-intensivist’s dilemma
- Open Access
- 24 July 2024
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 37 (3) , 279-287
Outcome of Aneurysmal Subarachnoid Hemorrhage Not Altered With Transatlantic Airplane Transfer: A Bicentric Matched Case-control Study
Objective: It is recommended that ruptured cerebral aneurysms are treated in a high-volume center within 72 hours of ictus. We assessed the impact of long-distance aeromedical evacuation in patients presenting aSAH. Methods: This case-control study compared patients with aneurysmal subarachnoid hemorrhage (aSAH) who had a 6750 km air transfer from Guadeloupe (a Caribbean island) to Paris, France, for neurointerventional management in a tertiary center with a matched cohort from Paris region treated in the same center over a 10-year period (2010 to 2019). The 2 populations were matched on age, sex, World Federation of Neurological Surgeons score, and Fisher score. The primary outcome was a 1-year modified Rankin Scale score ≤3. Secondary outcomes included time from diagnosis to securing aneurysm, 1-year mortality, and a cost analysis. Results: Among 128 consecutive aSAH transferred from Guadeloupe, 93 were matched with 93 patients from the Paris area. The proportion of patients with 1-year modified Rankin Scale ≤3 (75% vs 82%, respectively; P = 0.5) and 1-year mortality (18% vs 14%, respectively; P = 0.2) was similar in the Guadeloupe and Paris groups. The median (interquartile range: Q1, Q3) time from diagnosis to securing the aneurysm was higher in the patients from Guadeloupe than those from Paris (48 [30, 63] h vs 23 [12, 24] h, respectively; P < 0.001). Guadeloupean patients received mechanical ventilation (58% vs 38%; P < 0.001) and external ventricular drainage (55% vs 39%; P = 0.005) more often than those from Paris. The additional cost of treating a Guadeloupe patient in Paris was estimated at 7580 Euros or 17% of the estimated cost in Guadeloupe. Conclusions: Long-distance aeromedical evacuation of patients with aSAH from Guadeloupe to Paris resulted in a 25-hour increase in time to aneurysm coiling embolization time but did not impact 1-year functional outcomes or mortality.
- 24 July 2024
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 37 (3) , 279-287
Open AccessOutcome of Aneurysmal Subarachnoid Hemorrhage Not Altered With Transatlantic Airplane Transfer: A Bicentric Matched Case-control Study
Objective: It is recommended that ruptured cerebral aneurysms are treated in a high-volume center within 72 hours of ictus. We assessed the impact of long-distance aeromedical evacuation in patients presenting aSAH. Methods: This case-control study compared patients with aneurysmal subarachnoid hemorrhage (aSAH) who had a 6750 km air transfer from Guadeloupe (a Caribbean island) to Paris, France, for neurointerventional management in a tertiary center with a matched cohort from Paris region treated in the same center over a 10-year period (2010 to 2019). The 2 populations were matched on age, sex, World Federation of Neurological Surgeons score, and Fisher score. The primary outcome was a 1-year modified Rankin Scale score ≤3. Secondary outcomes included time from diagnosis to securing aneurysm, 1-year mortality, and a cost analysis. Results: Among 128 consecutive aSAH transferred from Guadeloupe, 93 were matched with 93 patients from the Paris area. The proportion of patients with 1-year modified Rankin Scale ≤3 (75% vs 82%, respectively; P = 0.5) and 1-year mortality (18% vs 14%, respectively; P = 0.2) was similar in the Guadeloupe and Paris groups. The median (interquartile range: Q1, Q3) time from diagnosis to securing the aneurysm was higher in the patients from Guadeloupe than those from Paris (48 [30, 63] h vs 23 [12, 24] h, respectively; P < 0.001). Guadeloupean patients received mechanical ventilation (58% vs 38%; P < 0.001) and external ventricular drainage (55% vs 39%; P = 0.005) more often than those from Paris. The additional cost of treating a Guadeloupe patient in Paris was estimated at 7580 Euros or 17% of the estimated cost in Guadeloupe. Conclusions: Long-distance aeromedical evacuation of patients with aSAH from Guadeloupe to Paris resulted in a 25-hour increase in time to aneurysm coiling embolization time but did not impact 1-year functional outcomes or mortality.
- Open Access
- 21 March 2024
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 15, 1308462
Case report: Simultaneous measurement of intracranial pressure and lumbar intrathecal pressure during epidural patch therapy for treating spontaneous intracranial hypotension syndrome. Spontaneous intracranial hypotension or spontaneous intraspinal hypovolume?
Objectives: Spontaneous intracranial hypotension (SIH) is frequently complicated by subacute subdural hematoma (SDH) and more rarely by bilateral thalamic ischemia. Here, we report a case of SIH-related SDH treated with three epidural patches (EPs), with follow-up of the intracranial pressure and lumbar intrathecal pressure.Methods: A 46-year-old man presented bilateral thalamic ischemia, then a growing SDH. After failure of urgent surgical evacuation, he underwent three saline EPs, two dynamic myelography examinations and one digital subtraction angiography–phlebography examination. However, because of no dural tear and no obstacle to the venous drainage of the vein of Galen, no therapeutic procedure was available, and the patient died.Results: The case exhibited a progressive increase in the transmission of lumbar intrathecal pressure to intracranial pressure during the three EPs. The EPs may have successfully treated the SIH, but the patient did not recover consciousness because of irreversible damage to both thalami.Conclusion: Clinicians should be aware of the bilateral thalamic ischemia picture that may be the presenting sign of SIH. Moreover, the key problem in the pathophysiology of SIH seems to be intraspinal and intracranial volumes rather than pressures. Therefore, intracranial hypotension syndrome might actually be an intraspinal hypovolume syndrome.
- 21 March 2024
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 15, 1308462
Open AccessCase report: Simultaneous measurement of intracranial pressure and lumbar intrathecal pressure during epidural patch therapy for treating spontaneous intracranial hypotension syndrome. Spontaneous intracranial hypotension or spontaneous intraspinal hypovolume?
Objectives: Spontaneous intracranial hypotension (SIH) is frequently complicated by subacute subdural hematoma (SDH) and more rarely by bilateral thalamic ischemia. Here, we report a case of SIH-related SDH treated with three epidural patches (EPs), with follow-up of the intracranial pressure and lumbar intrathecal pressure.Methods: A 46-year-old man presented bilateral thalamic ischemia, then a growing SDH. After failure of urgent surgical evacuation, he underwent three saline EPs, two dynamic myelography examinations and one digital subtraction angiography–phlebography examination. However, because of no dural tear and no obstacle to the venous drainage of the vein of Galen, no therapeutic procedure was available, and the patient died.Results: The case exhibited a progressive increase in the transmission of lumbar intrathecal pressure to intracranial pressure during the three EPs. The EPs may have successfully treated the SIH, but the patient did not recover consciousness because of irreversible damage to both thalami.Conclusion: Clinicians should be aware of the bilateral thalamic ischemia picture that may be the presenting sign of SIH. Moreover, the key problem in the pathophysiology of SIH seems to be intraspinal and intracranial volumes rather than pressures. Therefore, intracranial hypotension syndrome might actually be an intraspinal hypovolume syndrome.